Full Functional Knockout of Placental Growth Factor by Knockin with an Inactive Variant Able to Heterodimerize with VEGF-A

Cell Rep. 2018 Jun 19;23(12):3635-3646. doi: 10.1016/j.celrep.2018.05.067.

Abstract

Placental growth factor (PlGF) is a proangiogenic member of the vascular endothelial growth factor (VEGF) family playing a central role in pathological angiogenesis. PlGF-DE is a PlGF variant unable to bind vascular endothelial growth factor receptor 1 (VEGFR-1) but still able to generate heterodimer with VEGF-A. We have generated PlGF-DE knockin mice that are vital and fertile and show unaltered expression of Plgf, Vegf-a, Vegfr-1, and Vegfr-2 compared with wild-type mice. Interestingly, these mutants showed additional and remarkable angiogenesis impairment in tumor growth, hindlimb ischemia, and choroidal neovascularization compared with both PlGF knockout and wild-type mice. These findings provided insights on VEGF-A/PlGF heterodimer function, which was able to rescue neovascularization and vascular leakage in PlGF-DE knockin mice. Collectively, these data show that PlGF-DE knockin mouse could be considered the full functional knockout of PlGF, suggesting a reassessment of the phenotypes of knockout mice for the genes whose products are able to generate heterodimeric proteins.

Keywords: PlGF; VEGF/PlGF heterodimer; angiogenesis; mouse model; pathological neovascularization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Proliferation
  • Choroidal Neovascularization / metabolism
  • Choroidal Neovascularization / pathology
  • Cyclin-Dependent Kinase Inhibitor p27 / metabolism
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Gene Knock-In Techniques*
  • Male
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Nitric Oxide Synthase Type III / metabolism
  • Phosphorylation
  • Placenta Growth Factor / metabolism*
  • Protein Multimerization*
  • Vascular Endothelial Growth Factor A / metabolism*
  • Vascular Endothelial Growth Factor Receptor-2 / metabolism

Substances

  • Vascular Endothelial Growth Factor A
  • Placenta Growth Factor
  • Cyclin-Dependent Kinase Inhibitor p27
  • Nitric Oxide Synthase Type III
  • Vascular Endothelial Growth Factor Receptor-2
  • Extracellular Signal-Regulated MAP Kinases